Showing results (481-490 of 539) with videos related to
Sort By:
Pageof 54
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2022
Regulation of Laboratory-Developed Tests in Preventive Oncology: Emerging Needs and OpportunitiesKenneth Offit, Catherine M Sharkey, Dina Green, et al.Pediatrics|December 20, 2005
Relationship of surgical approach to neurodevelopmental outcomes in hypoplastic left heart syndromeWilliam T Mahle, Karen J Visconti, M Catherin Freier, et al.Immunity|April 22, 2021
The CD94/NKG2A inhibitory receptor educates uterine NK cells to optimize pregnancy outcomes in humans and miceNorman Shreeve, Delphine Depierreux, Delia Hawkes, et al.Biorxiv : the Preprint Server for Biology|November 1, 2024
Endogenous retrovirus-like proteins recruit UBQLN2 to stress granules and alter their functional propertiesHarihar M Mohan, Martin G Fernandez, Camellia Huang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical studyT M Behr, A L Salib, T Liersch, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2012
Quantitative immuno-SPECT monitoring of pretargeted radioimmunotherapy with a bispecific antibody in an intraperitoneal nude mouse model of human colon cancerRafke Schoffelen, Winette T A van der Graaf, Robert M Sharkey, et al.Science Advances|July 18, 2025
Endogenous retrovirus-like proteins recruit UBQLN2 to stress granules and shape their functional biologyHarihar M Mohan, Martin G Fernandez, Camellia Huang, et al.Neurobiology of Disease|July 13, 2020
Modeling UBQLN2-mediated neurodegenerative disease in mice: Shared and divergent properties of wild type and mutant UBQLN2 in phase separation, subcellular localization, altered proteostasis pathways, and selective cytotoxicityLisa M Sharkey, Stephanie S Sandoval-Pistorius, Shannon J Moore, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2015
Composition, Development, and Function of Uterine Innate Lymphoid CellsJean-Marc Doisne, Elisa Balmas, Selma Boulenouar, et al.Clinical Lymphoma|July 3, 2003
Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibodyDonald E Tsai, Ivan Maillard, Stephen J Schuster, et al.Pageof 54